New Nomenclature - NAFLD is now Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Continuing Education Company: www.cmemeeting.org/
Live Medical Conferences: www.cmemeeting.org/cme-confer...
Online CME: www.cmemeeting.org/online-pri...
Join us for an exclusive interview with Dr. Lisa VanWagner, a distinguished hepatologist and Associate Professor of Medicine at the University of Texas Southwestern Medical Center. In this captivating video, Dr. VanWagner discusses the groundbreaking advancements in liver disease nomenclature, including the introduction of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
This enlightening conversation took place during Dr. VanWagner's presentation at the 31st Annual Primary Care Conference in Kiawah Island, SC. At this event, she shared her expertise with a diverse audience of primary care professionals, emphasizing the importance of accurate diagnosis and management of steatotic liver disease.
As you watch this interview, you'll gain valuable insights into the newly introduced MASLD and MASH terminologies and their significance in the field of hepatology. Dr. VanWagner's presentation at the Primary Care Conference provided primary care practitioners with a comprehensive understanding of these concepts, empowering them to better identify and address liver-related conditions in their patients.
We invite you to subscribe to our channel for more engaging content on issues and medical education related to primary care. Join us in spreading awareness and improving patient outcomes through evidence-based approaches and ongoing professional development.
Don't miss this exclusive interview with Dr. Lisa VanWagner, where she shares her expertise on MASLD, MASH, and other crucial aspects of liver diseases. Together, let's enhance our understanding and management of liver conditions, driving progress in the field of hepatology and positively impacting patient care.